Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PRESERV (Prospective Randomized Evaluation to Study the Effects of Reduced Contrast Media on the Vitality of the Kidney) Pivotal Trial

NCT01168024 is registered in ClinicalTrials.gov with Osprey Medical, Inc as lead sponsor.

NCT NCT01168024
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01168024 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PRESERV (Prospective Randomized Evaluation to Study the Effects of Reduced Contrast Media on the Vitality of the Kidney) Pivotal Trial
Lead sponsor
Osprey Medical, Inc
Phase
Not applicable
Overall status
Terminated
Start date
December 31, 2012
Completion date
November 30, 2013
Enrollment
16 (actual)
Sites
21

Conditions

As the registry lists them; a condition with its own page is linked.

radiographic contrast agent nephropathy